1. Home
  2. SLRX vs DAKT Comparison

SLRX vs DAKT Comparison

Compare SLRX & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • DAKT
  • Stock Information
  • Founded
  • SLRX N/A
  • DAKT 1968
  • Country
  • SLRX United States
  • DAKT United States
  • Employees
  • SLRX N/A
  • DAKT N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • SLRX Health Care
  • DAKT Industrials
  • Exchange
  • SLRX Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • SLRX 2.9M
  • DAKT 710.0M
  • IPO Year
  • SLRX N/A
  • DAKT 1994
  • Fundamental
  • Price
  • SLRX $4.56
  • DAKT $22.74
  • Analyst Decision
  • SLRX
  • DAKT Strong Buy
  • Analyst Count
  • SLRX 0
  • DAKT 1
  • Target Price
  • SLRX N/A
  • DAKT $26.00
  • AVG Volume (30 Days)
  • SLRX 349.4K
  • DAKT 520.9K
  • Earning Date
  • SLRX 11-13-2025
  • DAKT 09-10-2025
  • Dividend Yield
  • SLRX N/A
  • DAKT N/A
  • EPS Growth
  • SLRX N/A
  • DAKT 9.66
  • EPS
  • SLRX N/A
  • DAKT 0.23
  • Revenue
  • SLRX N/A
  • DAKT $749,361,000.00
  • Revenue This Year
  • SLRX N/A
  • DAKT $10.38
  • Revenue Next Year
  • SLRX N/A
  • DAKT $6.41
  • P/E Ratio
  • SLRX N/A
  • DAKT $97.71
  • Revenue Growth
  • SLRX N/A
  • DAKT N/A
  • 52 Week Low
  • SLRX $4.23
  • DAKT $10.24
  • 52 Week High
  • SLRX $108.00
  • DAKT $24.38
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 35.23
  • DAKT 73.69
  • Support Level
  • SLRX $4.79
  • DAKT $22.47
  • Resistance Level
  • SLRX $5.90
  • DAKT $24.38
  • Average True Range (ATR)
  • SLRX 0.41
  • DAKT 0.89
  • MACD
  • SLRX 0.20
  • DAKT 0.52
  • Stochastic Oscillator
  • SLRX 19.76
  • DAKT 78.04

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: